Genzyme | Evaluate

December 14, 2016

After US approval, Vericel’s headache begins

November 04, 2016

Snippet roundup: Infinity sells duvelisib, Celldex buys Kolltan and Zimmer Biomet has supply woes

October 26, 2016

Buy or build – big pharma’s freshness dilemma

August 24, 2016

Few M&A teams venture beyond domestic borders

July 06, 2016

Sanofi and Medivation make peace, but there’s no deal yet

March 11, 2016

Pivotal data overshadows Vericel’s heart failure win

February 01, 2016

Therapy focus – Multiple myeloma pricing set to feel the heat

December 15, 2015

Sanofi-Boehringer asset swap not the deal you were looking for

November 10, 2015

Sanofi's post-Lantus strategy will rely on an acquisition

November 06, 2015

Sanofi bizdev gets busy and brings in Lexicon

October 29, 2015

Halloween gives Sanofi investors another fright

Load More